US 6380167
Methods for anti-tumor therapy
expired A61KA61K31/215A61K31/365
Quick answer
US patent 6380167 (Methods for anti-tumor therapy) held by PrimeCyte, Inc. expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- PrimeCyte, Inc.
- Grant date
- Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/215, A61K31/365, A61K31/585, A61K31/704